๐Ÿ’Ÿ PDF

ํ˜„๋‚ด - PUPD & DI (06.18 ์ตœ์ข…).jpg

์•„๋ž˜๋Š” ํ•„๊ธฐ


ํ•ญ์ƒ์„ฑ ๊ธฐ๋Šฅ์ด ์ •์ƒ์ด๋ผ๋ฉด ๋‹ค์Œ&๋‹ค๋‡จ๊ฐ€ ๊ฐ™์ด ์˜ค๋Š” ๊ฒฝ์šฐ๊ฐ€ ๋งŽ๋‹ค.

  • Anuria (๋ฌด๋‡จ) : ์˜ค์คŒ์ด ์ œ๋Œ€๋กœ ์ƒ์„ฑ๋˜์ง€ ์•Š๊ฑฐ๋‚˜, ๋ฐฐ์ถœ๋˜์ง€ ์•Š์Œ
    • ์ฃผ๋กœ ์š”๋กœ ํ์ƒ‰์œผ๋กœ ์ธํ•ด ๋ฐœ์ƒ, AKI(๊ธ‰์„ฑ ์‹ ๋ถ€์ „, Acute Kidney Injury) ์˜์‹ฌ
  • Oliguria (ํ•๋‡จ) : urine output ๊ฐ์†Œ
    • ๋ถ€๋ถ„ ์š”๋กœ ํ์ƒ‰, ์‹ ๋ถ€์ „ ์˜์‹ฌ, ์ „์‹  ํƒˆ์ˆ˜ ์งˆํ™˜, UTI (์š”๋กœ๊ฐ์—ผ์ฆ)
  • Polyuria (๋‹ค๋‡จ) : ๋น„์ •์ƒ์ ์œผ๋กœ ๋งŽ์€ urine ์ƒ์„ฑ ๋˜๋Š” ๋ฐฐ์ถœ / ์ฃผ๋กœ ์ƒ๋ถ€ ๋น„๋‡จ๊ณ„ ๋ฌธ์ œ
  • Dysuria (๋ฐฐ๋‡จํ†ต) : ๋ฐฐ๋‡จ ๊ณค๋ž€, ํ†ต์ฆ
  • Stranguia (ํ†ต์ฆ๋ฐฐ๋‡จ) : ๋А๋ฆฌ๊ณ  ๊ณ ํ†ต์Šค๋Ÿฌ์šด ๋ฐฐ๋‡จ
    • ์š”๋„, ๋ฐฉ๊ด‘์˜ ๊ทผ์œก ๊ฒฝ๋ จ(spasms) ๋“ฑ์— ์˜ํ•จ
  • Pollakiuria (๋นˆ๋‡จ) : ์†Œ๋Ÿ‰์”ฉ ์ž์ฃผ ๋ฐฐ๋‡จ / ์ฃผ๋กœ ํ•˜๋ถ€ ์š”๋กœ๊ณ„ ๋ฌธ์ œ
  • Urinary incontinence (์š”์‹ค๊ธˆ) : ๋น„์ž๋ฐœ์  ๋ฐฐ๋‡จ (ํ†ต์ œ ๋ถˆ๊ฐ€)
  • Nocturia (์•ผ๋‡จ) : ๋ฐค์— ๋ฐฐ๋‡จํ•˜๊ณ  ์‹ถ์–ด์ง, ๋…ธ๋ น ๋™๋ฌผ์—์„œ ์ฃผ๋กœ ๋ฐœ์ƒ
    • ๋‹ค๋‡จ๋‚˜ ์š”์‹ค๊ธˆ์˜ ์ดˆ๊ธฐ ์ฆ์ƒ์ผ ์ˆ˜ ์žˆ์Œ
  • Hematuria (ํ˜ˆ๋‡จ)
  • Pyuria (๋†๋‡จ)
  • Malodorous urine (์•…์ทจ ๋‚˜๋Š” ์†Œ๋ณ€)

๋‹ค๋‡จ : ํ•œ ๋ฒˆ์— ์‹œ์›ํ•˜๊ฒŒ ๋งŽ์ด ๋ˆ„๋Š” ๊ฒƒ ๋นˆ๋‡จ : ์ฐ”๋”์ฐ”๋” ๋งŽ์ด ๋ˆ„๋Š” ๊ฒƒ

Definition

  • ์š”๋ถ•์ฆ์˜ ๊ฒฝ์šฐ ํ—ท๊ฐˆ๋ฆฌ์ง€ ์•Š์„ ๋งŒํผ ๋งŽ์ด
  • ์ฟ ์‹ฑ ๋“ฑ์€ grey zone, ์• ๋งค
  • Polyuria (PU) :
    • Normal : 1-2ml/kg/hour
  • Polydipsia (PD) โ€œ
Polyuria (PU)Polydipsia (PD)
Normal
Grey zone
Poly-

๋ฌด์—‡์ด ์„ ํ–‰๋˜์—ˆ๋Š”์ง€๋ฅผ ํŒŒ์•…ํ•˜๋Š” ๊ฒŒ ์ง„๋‹จ์— ๋„์›€์ด ๋œ๋‹ค.

  • PU โ†’ PD : primary polyuria, secondary polydipsia, 95% ์—ฌ๊ธฐ์— ํ•ด๋‹น
  • PD โ†’ PU : primary polydipsia, secondary polyuria, ์†Œ์ˆ˜

Influencing Factors

์ผ์‹œ์ ์ธ ์ฆ์ƒ์ผ ์ˆ˜ ์žˆ์œผ๋‹ˆ ์—ฌ๋Ÿฌ ์›์ธ์„ ํŒŒ์•…ํ•ด์•ผ ํ•จ.

Differentiating

์ž„์ƒ์ ์œผ๋กœ ์—ฌ๊ธฐ์„œ๋ถ€ํ„ฐ ๊ตฌ๋ถ„ํ•˜์ง„ ์•Š์ง€๋งŒ..

- Glucocorticoids
- Diuretics
- Chronic renal disease
๋‹ค์Œ๋‹ค๋‡จ ํ™˜์ž๊ฐ€ ์˜ค๋ฉด..
History taking๋ฌผ์— ๋Œ€ํ•œ ์ง‘์ฐฉ
Physical examinationFull-screening
๋ฌผ์„ ๋„ˆ๋ฌด ๋งŽ์ด ๋งˆ์‹œ๋‹ˆ ๋ฌผ์„ ๋Š๋Š”๋‹ค? โ†’ ๋ณด์ƒ ์ž‘์šฉ์ด ๋Š์–ด์ง€๋Š” ๊ฒƒ
โ†’ ํƒˆ์ˆ˜๋กœ ์ด์–ด์ง โ†’ ์‹ ๊ฒฝ์ฆ์ƒ๊นŒ์ง€ ์ด์–ด์งˆ ์ˆ˜๋„.
Urinalysis & Urine culture
Blood analysisScreening ์ธก๋ฉด
Imaging- Radiography
- U
- CT
Additional testing๊ฐ์—ผ ๊ฒ€์‚ฌ
ํ˜ธ๋ฅด๋ชฌ ๊ฒ€์‚ฌ

Water homeostasis

  • ingestion : drinking, food
  • excretion : urine, the respiratory tract, feces
    • ADH ์ฆ๊ฐ€ โ†’ ์†Œ๋ณ€์„ ๋ชธ ์•ˆ์œผ๋กœ ํก์ˆ˜ โ†’ ๋ฐฐ๋‡จ๋Ÿ‰ ๊ฐ์†Œ

ADH

ADH์— ๋ฌธ์ œ๊ฐ€ ์ƒ๊ธด ๊ฒฝ์šฐ๊ฐ€ ๋งŽ๋‹ค. ๋‡Œํ•˜์ˆ˜์ฒด ํ›„์—ฝ์„ ํ†ตํ•ด ๋ถ„๋น„๋˜๋Š” ํ˜ธ๋ฅด๋ชฌ. ์†Œ๋ณ€์—์„œ ๋นจ์•„๋“ค์—ฌ์„œ ๋†์ถ•๋œ ์†Œ๋ณ€์„ ์œ ๋ฐœ. ํ˜ˆ๊ด€ ์ˆ˜์ถ•, ์ด์ƒ ํ–‰๋™, ๋‡Œํ•˜์ˆ˜์ฒด์˜ ์ „์—ฝ์— ์˜ํ–ฅ

Diuresis

  • ์š”๋ถ•์ฆ :

  • ๋Œ€๋ถ€๋ถ„ ์šฉ์งˆ์ด๋‡จ

    • ์†Œ๋ณ€ ์•ˆ์— ์ปค๋‹ค๋ž€ ๋ฌผ์งˆ๋“ค์ด ๋งŽ์•„์„œ
    • AQP-2, ADH๋Š” ์ œ๋Œ€๋กœ ์ž‘์šฉํ•˜์ง€๋งŒ, ์šฉ์งˆ์ด ์ปค์„œ ๋ง‰ ํ˜๋Ÿฌ๊ฐ€๋‹ˆ๊นŒ ์ •์ƒ์ ์œผ๋กœ ๋ฌผ์„ ํก์ˆ˜ํ•  ์‹œ๊ฐ„์ด ์—†์Œ
    • Diabetes mellitus :
    • mannitol
  • Water diuresis

    • ๋ฌผ์ด ๋งŽ์ด ๋“ค์–ด์˜ค๋ฉด ์šฉ์งˆ์€ ์ ์–ด์ง, ๋ฌฝ์–ด์ง, ADH ๋ถ„๋น„ ๊ฐ์†Œ, AQP์ด ์ œ๋Œ€๋กœ ์ž‘์šฉํ•˜์ง€ ์•Š์Œ
    • ๋ฌผ์„ ๋นจ์•„๋“ค์ด๋Š” ๋ฉ”์ปค๋‹ˆ์ฆ˜์ด ์—†์–ด ๋ฌผ์ด ๊ณ„์† ๋น ์ ธ๋‚˜๊ฐ

Primary polydipsia

  • ๋งค์šฐ ๋“œ๋ฌธ ๊ฒฝ์šฐ.
  • Psychogenic polydipsia (PP) : ๋‡Œ, ์ •์‹ ์˜ ๋ณ‘์ ์ธ ๋ฌธ์ œ๋กœ ๊ฐ•๋ฐ•์ ์œผ๋กœ ๋ฌผ์„ ๋งŽ์ด ๋งˆ์‹œ๋Š” ๊ฒƒ.
  • ๊ฐˆ์ฆ ์ค‘์ถ”์˜ ์†์ƒ, ์ด๋ก ์ ์œผ๋กœ ๊ฐ€๋Šฅํ•˜๋‚˜ ๊ทนํžˆ ๋“œ๋ฌผ๋‹ค.

Primary polyuria (with compensatory polydipsia)

  • ๋‹ค๋‡จ๊ฐ€ ๋จผ์ € ์ƒ๊ฒจ ๋ณด์ƒ์„ฑ์œผ๋กœ ๋‹ค์Œ.
  • ์ˆ˜๋ถ„์ด๋‡จ(ADH ์ž์ฒด์— ๋ฌธ์ œ)์ธ์ง€, ์šฉ์งˆ์ด๋‡จ์ธ์ง€ ๊ตฌ๋ถ„ ํ•„์š”.
  • ์šฉ์งˆ์ด๋‡จ
    • Diabetes mellitus (๋‹น๋‡จ)
    • ์‹ ์žฅ์งˆํ™˜
    • Post-obstructive diuresis (์š”๋กœ๊ฐ€ ๋ง‰ํ˜€ ๋ฉฐ์น  ๋ฐฐ๋‡จ๋ฅผ ๋ชปํ–ˆ๋‹ค? โ†’ ๋ฌธ์ œ๊ฐ€ ํ•ด์†Œ๋˜์–ด๋„, ๋ฐฐ๋‡จ ๊ธฐ๋Šฅ์„ ํšŒ๋ณตํ•˜๊ธฐ๊นŒ์ง€ ์‹œ๊ฐ„์ด ๊ฑธ๋ฆฌ๋Š”๋ฐ ๊ทธ๋™์•ˆ ์šฉ์งˆ์ด๋‡จ๊ฐ€ ๋ฐœ์ƒ ๊ฐ€๋Šฅ.)
    • Primary renal glycosuria (์†Œ๋ณ€์œผ๋กœ ํฌ๋„๋‹น์ด ์งˆ์งˆ ์ƒˆ์–ด๋‚˜๊ฐ)

Diabetes insipidus (DI, ์š”๋ถ•์ฆ)

  • ๋‹น๋‡จ๊ฐ€ ๋” ๋งŽ์ด ๋ฐœ์ƒ โ†’ ๋‹น๋‡จ๋ฅผ ๊ทธ๋ƒฅ diabetes๋ผ๊ณ  ํ•˜๊ธฐ๋„.
  • DI = ์•„๋ฌด ๋ง›์ด ์—†๋Š” ์†Œ๋ณ€์ด ํ๋ฅธ๋‹ค
  • DM = ๋‹ฌ์ฝคํ•œ ์†Œ๋ณ€์ด ํ๋ฅธ๋‹ค

๊ตฌ๋ถ„

  • CDI
    • Complete
    • Partial
    • idiopathic ๋งŽ์Œ
    • trauma, infection
    • ๋‡Œ์— cyst๋‚˜ ์ข…์–‘์ด ์žˆ๋Š” ๊ฒฝ์šฐ(rare)
  • NDI : ์‹ ์žฅ ๋•Œ๋ฌธ
    • Primary : ์„ ์ฒœ์ ์œผ๋กœ ADH์˜ ์ž‘์šฉ์„ ๋ชป ๋ฐ›์•„๋“ค์ด๋Š” ๊ฒฝ์šฐ, ๊ทนํžˆ ๋“œ๋ฌผ๋‹ค
    • Secondary (๊ฐ€์žฅ ๋งŽ์Œ) : ๋‹ค๋ฅธ ์งˆํ™˜์œผ๋กœ ์ธํ•ด 2์ฐจ์ ์œผ๋กœ ADH๋ฅผ ๋ฐ›์•„๋“ค์ด๋Š” ์‹ ์žฅ ๊ธฐ๋Šฅ์ด ๋–จ์–ด์ง

Diseases associated with secondary NDI

  • ์‹ ์žฅ : Renal failure, Renal medullary solute washeout (์‚ผํˆฌ์•• ์ฐจ๊ฐ€ ์—†์–ด์„œ ๊ทธ๋ƒฅ ์šฉ์งˆ์ด ๋น ์ ธ๋‚˜๊ฐ€๋Š” ํ˜„์ƒ)
  • ๊ฐ‘์ƒ์„  :
  • ๊ฐ„ : Hepatic disease

History & Clinical signs

  • No age, breed or sex predilection
  • ๊ฐ‘์ž๊ธฐ PUPD
  • ์‹ ๊ฒฝ์ฆ์ƒ ๋ณ‘๋ฐœ ๊ฐ€๋Šฅ
  • ๋‹ค์Œ๋‹ค๋‡จ ์™ธ์— ์ฆ์ƒ ๊ฑฐ์˜ ์—†์Œ. ๋‹ค ๊ดœ์ฐฎ์€๋ฐ ๋งŽ์ด ๋งˆ์‹œ๊ณ  ๋งŽ์ด ์‹ธ์š” โ†’ ์š”๋ถ•์ฆ์ผ ๋•Œ ๋งŽ์Œ.
์ง„๋‹จ
History taking
Clinical signs
Physical examination
Routine laboratory tests
Urinalysis- Glycosuria : ๋‹น๋งŒ ๋‚˜๊ฐ
- Proteinuria
- Pyuria, Bacteriuria
Urine specific gravityUSG < 1.006
(์ค‘์ถ”์„ฑ์ด๋ฉด 1.013 ์ •๋„๊นŒ์ง€ variation โ†’ ๋‹ค์–‘ํ•œ ๊ฒ€์‚ฌ ์ข…ํ•ฉ)
Blood๊ฑฐ์˜ ์ •์ƒ์œผ๋กœ ๋‚˜์˜ฌ ์ˆ˜ ์žˆ์Œ!
> ์š”๋ถ•์ฆ์€ ์›Œ๋‚™ ๋“œ๋ฌผ๊ธฐ์—, ๋‹ค๋ฅธ ๊ฒ€์‚ฌ๋„ ๋” ํ•ด๋ณด๊ณ  ๊ทธ๋ฆฌ๊ณ  ์ง„๋‹จ
Complete blood count
Serum biochemical profileํƒˆ์ˆ˜๋กœ ์ธํ•œ prerenal azotemia
BUN ๊ฐ์†Œ
Serum biochemical profile-์™€ -์˜ ์ฐจ์ด๋Š” ์—ฌ๊ธฐ์„œ
- Hypernatremia : ์†Œ๋ณ€์ด ๋‚˜๊ฐ€๋Š” ๋ฐ ๋” ํฌ๋‹ค
- Hyponatremia : primary PD๋Š” ๋งˆ์‹œ๋Š” ๊ฒŒ ๋” ์ปค์„œ

Definitive Diagnostics

Random plasam osmolality

๋ฌผ์„ ๋งŽ์ด ๋จน์œผ๋‹ˆ๊นŒ > overlapping์ด ์žˆ์–ด์„œ

CDI vs NDI ๊ฐ๋ณ„ ์œ„ํ•ด ๋ฐ”์†Œํ”„๋ ˆ์‹ , ์ˆ˜๋ถ„์ œํ•œ๊ฒ€์‚ฌ

Synthetic vasopressin therapy

ํ•ฉ์„ฑ vasopressin ํˆฌ์•ฝ โ†’ ํ•ญ์ด๋‡จ ์ž‘์šฉ์ด ์ผ์–ด๋‚˜๋Š”์ง€ ํ™•์ธ

  • CDI : ADH ์ž‘์šฉ X โ†’ vasopressin์„ ๋„ฃ์–ด์ฃผ๋ฉด ํ•ญ์ด๋‡จ ์ž‘์šฉ์ด ์ •์ƒ์ ์œผ๋กœ ๋‚˜ํƒ€๋‚จ โ†’ ์†Œ๋ณ€๋Ÿ‰ ๊ฐ์†Œ, ๋‹ค์Œ ํ•ด์†Œ

  • NDI : ์ •์ƒ์ ์œผ๋กœ ๋‚˜์˜ค๋Š” ํ˜ธ๋ฅด๋ชฌ์˜ ์ž‘์šฉ์ด ์•ˆ ๋˜๋Š” ๊ฒƒ โ†’ ๋šœ๋ ทํ•œ ๊ฐœ์„  ์—†์Œ

    • ์•„์ฃผ ์•ฝ๊ฐ„ ์˜ฌ๋ผ๊ฐ€๋Š” ์ฐจ์ด๋Š” ๋‚˜ํƒ€๋‚จ
  • ๋ถ„๋ฌด ๋˜๋Š” ์ ์ 

  • Regulary washout ๋•Œ๋ฌธ์— ๊ฐœ์„  ํšจ๊ณผ๊ฐ€ ๋ฐ”๋กœ ๋‚˜ํƒ€๋‚˜์ง€ ์•Š๊ณ , ์ผ์ฃผ์ผ ์ •๋„ ๊ฑธ๋ฆผ

Modified water deprivation test (MWDT, ์ˆ˜๋ถ„ ์ œํ•œ ๊ฒ€์‚ฌ)

Vasopressin ํˆฌ์•ฝ๋ณด๋‹ค ๋” ๋ช…ํ™• ํƒˆ์ˆ˜๋ฅผ ์„ธ๊ฒŒ ์œ ๋ฐœ โ†’ ADH ํ˜ธ๋ฅด๋ชฌ์˜ ์ž‘์šฉ ํ‰๊ฐ€

ํ•˜์ง€๋งŒ ์ด๋ฏธ ์š”๋ถ•์ฆ์ด ์žˆ๋Š”๋ฐ.. ํƒˆ์ˆ˜ ์‹ฌํ™”, ์˜ค์คŒ์€ ๊ณ„์† ๋‚˜๊ฐ€๋‹ˆ๊นŒ ๋‚˜ํŠธ๋ฅจ์ด ์Œ“์ž„, ์ง„๋‹จ์  ์ด์ ๋งŒ ์žˆ์ง€, ์žฅ์ ์€ ์—†๊ณ  risk๊ฐ€ ์žˆ์Œ ํƒˆ์ˆ˜ ์™€์„œ ๊ธ‰์‚ฌ ํ•  ์ˆ˜ ์žˆ๊ณ  ๋ฐœ์ž‘ ํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค..? ์‹ค์ œ๋กœ ์‹œํ–‰ํ•  ๋•Œ๊ฐ€ ๋งŽ์ง„ ์•Š์€.

Phase โ… Phase โ…กPhase โ…ข
์ฒœ์ฒœํžˆ ๋ฌผ์„ ์ค„์—ฌ๋‚˜๊ฐ์•„์˜ˆ ๋ฌผ์„ ์ค‘๋‹จ,
5% ํƒˆ์ˆ˜ ์œ ๋ฐœ (์ฒด์ค‘ 5% ๋น ์งˆ ๋•Œ๊นŒ์ง€)
์ค‘์ถ”์„ฑ, ์‹ ์„ฑ
complete & partial ๊ตฌ๋ถ„
USG๊ฐ€ ์˜ค๋ฅด๋ฉด primary PD๋กœ ์ž ์ •์ง„๋‹จ ๊ฐ€๋Šฅํ•˜์ง€๋งŒ
์ด๋ ‡๊ฒŒ ๋๋‚  ๋•Œ๋Š” ์ž˜ ์—†์Œ
์š”๋น„์ค‘์˜ ์ฆ๊ฐ€๊ฐ€ ๊ฐ€์žฅ
1-2์‹œ๊ฐ„๋งˆ๋‹ค ๋‡จํŒฉ ๋น„์šฐ๊ณ , ์š”๋น„์ค‘ ์ธก์ •
ํ•˜๋ฉด์„œ ํƒˆ์ˆ˜ ์œ ๋ฐœ
vasopressin
โ‡’ ์š”๋น„์ค‘์ด ์ •์ƒ์œผ๋กœ ์˜ฌ๋ž๋‹ค?
์Œ์ˆ˜๋Ÿ‰์˜ ๋ฌธ์ œ์˜€๋˜ ๊ฑฐ๋‹ˆ, primary PD๋กœ ์ง„๋‹จ.
๋๋‚˜๋ฉด ๋‹ค์‹œ ๋ฌผ์„ ์ฃผ๋Š”๋ฐ,
๋ฌผ์ค‘๋… ์ƒํƒœ ์ฃผ์˜
์ฒœ์ฒœํžˆ ๋ฌผ์„ ์ค˜์•ผ ํ•จ

์š”๋น„์ค‘ ํ‰๊ฐ€๊ฐ€ ์ค‘์š”

Plasma AVP concentration

ํƒˆ์ˆ˜ ํ‰๊ฐ€๋ฅผ ์ธ์œ„์ ์œผ๋กœ ์กฐ๊ธˆ ํ•˜๋Š” ๊ฒŒ ํ™•์‹ค

Treatment

  • ์น˜๋ฃŒ ๋ฐฉ๋ฒ•์€ ๋”ฑํžˆ ์—†์ง€๋งŒ
  • ๊ทธ๋‚˜๋งˆ ํ•ญ์ด๋‡จ ํ˜ธ๋ฅด๋ชฌ ํˆฌ์—ฌ
CDI- Vasopressin ํˆฌ์—ฌ
- Low-sodium diet (์ €์—ผ์‹์ด)
Primary NDI์น˜๋ฃŒ๋ฐ˜์‘์ด ์ข‹์€ ํŽธ์€..
Secondary NDI๊ธฐ์ €์งˆํ™˜ ์น˜๋ฃŒ ์ž˜
Primary PD- ์ฒœ์ฒœํžˆ ๋ฌผ์„ ์ œํ•œ
but ๊ด‘์ ์œผ๋กœ ์ง‘์ฐฉํ•˜๊ธฐ์—..
ํ™˜๊ฒฝ์„ ๋ฐ”๊ฟ”์ฃผ๊ณ , ๋‹ค๋ฅธ ์ฆ๊ฑฐ์›€์„ ์ฃผ๋Š” ๋“ฏ

DDAVP

  • ํ•ฉ์„ฑ ๋ฐ”์†Œํ”„๋ ˆ์‹ , natural๋ณด๋‹ค 3๋ฐฐ ์ •๋„ ๋›ฐ์–ด๋‚œ,
  • efficacy๋Š” SC์—์„œ ๊ฐ€์žฅ ์ข‹์€๋ฐ, ๋ฐ˜๊ฐ๊ธฐ๊ฐ€ ์งง์•„์„œ ํ•˜๋ฃจ 1๋ฒˆ ์ฃผ์‚ฌ ํ•„์š”. (๋ฐ˜๋ณตํˆฌ์•ฝ์˜ ๋‹จ์ )
  • ๊ฒฝ๊ตฌ, ๊ฒฐ๋ง‰๋‚ญ์œผ๋กœ ํˆฌ์—ฌํ•  ๋•Œ๊ฐ€ ๋งŽ์Œ.
  • ๋„ˆ๋ฌด ๋งŽ์œผ๋ฉด โ†’ hyponatremia, water intoxication
Chlorpropamide
  • ํ˜ˆ๋‹น์„ ๋‚ฎ์ถฐ์ฃผ๋Š” ์•ฝ๋ฌผ
  • ์š”๋ถ•์ฆ ํ™˜์ž์—์„œ๋„ ๋„์›€์ด ๋จ. ADH ํ•ญ์ง„
  • partial์—์„œ ์„ ํƒ์ ์œผ๋กœ ์“ธ ์ˆ˜
Thiazide diuretics (์•ฝ๋ฆฌ1(B) - Ch.17 ์ด๋‡จ์ œ)

์›์œ„์„ธ๋‡จ๊ด€์—์„œ ๋ฌผ์˜ ์žฌํก์ˆ˜๋ฅผ ์ด‰์ง„ Na, K๋„ ๊ฐ™์ด ๋‚˜๊ฐ ๋ณด์ƒ์ž‘์šฉ์œผ๋กœ PT์—์„œ ๋ฌผ์„ ๋นจ์•„๋“ค์ด๋Š” ํšจ๊ณผ, Na๋„ ๊ฐ™์ด ๋นจ๋ ค๋“ค์–ด๊ฐ; K์€ ๋”ธ๋ ค๊ฐ€์ง€ X

Thiazide ์ด๋‡จ์ œ๋Š” ์š”๋ถ•์ฆ ํ™˜์ž์—์„œ ์ข€ ํšจ๊ณผ๋ฅผ ๋ณด์ด์ง€๋งŒ, ๋‹ค๋ฅธ ๊ณ„์—ด ์ด๋‡จ์ œ๋Š” X

Prognosis

CDI- ๋ฌผ ์ฃผ๊ณ , ์ž˜ ์น˜๋ฃŒํ•ด์ฃผ๋ฉด ์˜ˆํ›„ ๊ดœ์ฐฎ์ง€๋งŒ
- ์ข…์–‘๊ณผ ํ•จ๊ป˜ ๋‚˜ํƒ€๋‚˜๋ฉด X
primary NDI
secondary NDI

๋‹ค์Œ๋‹ค๋‡จ๊ฐ€ ์š”๋ถ•์ฆ ๋•Œ๋ฌธ์ผ ๋•Œ๋Š” ์ž˜ ์—†๋‹ค. ๋‹ค๋ฅธ ํ˜ธ๋ฅด๋ชฌ ๊ฒ€์‚ฌ๋ฅผ ๋จผ์ € ํ•˜๋Š” ๊ฒŒ ์ข‹๋‹ค.